Service d' Anesthésie Réanimation Chirurgicale
Strasbourg, 67091, France
NCT Number: NCT04374734
Acute respiratory failure (ARF) is a common condition and a common reason for urgent medical consultation. Assessing the extent of respiratory impairment is important to improve the management of patients with ARF. When Acute respiratory failure is caused by pathology of the pulmonary parenchyma, quantification of pulmonary radiographic involvement may be a component of the initial assessment of severity. This radiographic quantification would only be usable in clinical routine if it can be automated and provide a real-time result.
The objective of this work is to assess the feasibility of an automated technique for quantifying radiological lung damage in situations of known or potential ARF.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Strasbourg, 67091, France
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 2 months
University Hospital, Strasbourg, France
Other
Automated Quantification of Radiological Pulmonary Involvement in Acute Respiratory Failure
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04306393
Coronaviridae Infections, Coronavirus
Birmingham, Alabama, United States
View Trial DetailsNCT04584658
COVID-19, Coronaviridae Infections
Cambridge, United Kingdom
View Trial DetailsNCT04558476
COVID-19, Corona Virus Infection
Ottignies, Brabant Wallon, Belgium
View Trial DetailsNCT05097677
COVID-19, COVID-19 Acute Bronchitis
Antwerp, Belgium
View Trial Details